Raplon is an anesthetic used to relax skeletal muscles during surgery. It is also known as rapacuronium bromide. Approved by the FDA in August of 1999, Raplon is being voluntarily pulled off the market by its manufacturer Organon, since it may cause severe breathing difficulties like bronchospasm and death.